Tetraphase Pharmaceu
(TTPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Sales | 4,283 | 1,151 | 11,579 | 1,891 | 2,528 |
| Gross Profit | 4,055 | 1,151 | 11,579 | 1,891 | 2,528 |
| Operating Expenses | 25,672 | 21,146 | 21,535 | 23,832 | 26,346 |
| Operating Income | -21,389 | -19,995 | -9,956 | -21,941 | -23,818 |
| Other Income | -92 | 437 | 413 | 365 | 343 |
| Pre-tax Income | -21,481 | -19,558 | -9,543 | -21,576 | -23,475 |
| Net Income Continuous | -21,481 | -19,558 | -9,543 | -21,576 | -23,475 |
| Net Income | $-21,481 | $-19,558 | $-9,543 | $-21,576 | $-23,475 |
| EPS Basic Total Ops | -8.09 | -7.39 | -3.60 | -8.40 | -7.60 |
| EPS Basic Continuous Ops | -8.05 | -7.39 | -3.68 | -8.36 | -7.48 |
| EPS Diluted Total Ops | -8.09 | -7.39 | -3.60 | -8.40 | -7.60 |
| EPS Diluted Continuous Ops | -8.05 | -7.39 | -3.68 | -8.36 | -7.48 |
| EPS Diluted Before Non-Recurring Items | -8.00 | -7.40 | N/A | N/A | N/A |
| EBITDA(a) | $-21,170 | $-19,875 | $-9,835 | $-21,825 | $-23,702 |